ACQUIRED · 2022
Who Acquired Osteogenics Biomedical Inc. (Allotech and OBI Biologics)?
Envista Holdings Corp. · $126.1M
The acquisition
Osteogenics Biomedical Inc. (Allotech and OBI Biologics) was acquired by Envista Holdings Corp. in 2022 for $126.1M. at 4.20× revenue.
Osteogenics Biomedical Inc. (Allotech and OBI Biologics) at time of acquisition
Revenue
$30.0M
Deal value
$126.1M
Other acquisitions by Envista Holdings Corp.
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Carestream Dental Intraoral Scanner Business · 2022 · $577.6M · 32.1× EBITDA
Similar dental practice acquisitions
- 12 Dental Practices · acquired by DentalCorp in 2025 · $6.2M
- 8 Dental Practices · acquired by DentalCorp in 2025 · $3.0M
- Dentalcorp Holdings Ltd. · acquired by GTCR in 2025 · $2.40B
- Donte Group · acquired by Ontario Teachers' Pension Plan in 2025 · $1.17B
- Smile Design Dentistry · acquired by Heartland Dental in 2025 · $165.0M
Run a valuation for a similar dental practice business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the dental practice calculator →More on dental practice valuations
- Value a medical practice
- Value a veterinary practice
- Value a physical therapy
- Dental Practice valuation calculator· head-term variant
- Dental Practice median multiples· real-deal benchmarks
- How to value a dental practice· long-form guide
Sourced from SEC filings and press releases. Full deal page.
Citation: ExitValue.ai. (2022). Osteogenics Biomedical Inc. (Allotech and OBI Biologics) acquired by Envista Holdings Corp.. https://exitvalue.ai/acquired/osteogenics-biomedical-inc-allotech-and-obi-biologics